Medicare and Medicaid Programs: Application From the Accreditation Commission for Health Care, Inc. for Continued Approval of Its End-Stage Renal Disease (ESRD) Accreditation Program, 16981-16983 [2023-05761]
Download as PDF
Federal Register / Vol. 88, No. 54 / Tuesday, March 21, 2023 / Notices
that the use of non-compete agreements
has a tendency to harm competition and
workers, but fails to provide facts to
support the hypothesized outcome.
Similar to the Commission’s complaints
against O–I Glass and Ardagh Group,
the complaint against Anchor Glass
suffers from several omissions. It does
not allege that the company’s noncompete provisions are unreasonable
based on their temporal length, subject
matter, or geographic scope; neither
does it allege that the non-compete
clauses were enforced. The complaint
does not make factual allegations
regarding the inability of a competing
rival in the glass container industry to
enter or expand. While the complaint
alleges that the non-compete clauses
reduce employee mobility, thereby
leading to lower wages, reduced
benefits, and less favorable working
conditions, the complaint does not
identify a relevant market for particular
types of labor and fails to allege a
market effect on wages or other terms of
employment.
For the reasons outlined here and
explained in detail in my January 2023
statement, I dissent.
[FR Doc. 2023–05701 Filed 3–20–23; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2022–0044]
CDC Recommendations for Hepatitis B
Screening and Testing—United States,
2022
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: General notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), announces the
availability of the final CDC
Recommendations for Hepatitis B
Screening and Testing—United States,
2022.
DATES: The final document was
published as an MMWR Reports &
Recommendations on March 10, 2023.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
ftc_gov/pdf/p221202sec5enforcementpolicy
statement_002.pdf; Christine S. Wilson, Dissenting
Statement Regarding the ‘‘Policy Statement
Regarding the Scope of Unfair Methods of
Competition Under Section 5 of the Federal Trade
Commission Act’’ (Nov. 10, 2022), https://
www.ftc.gov/system/files/ftc_gov/pdf/
P221202Section5PolicyWilsonDissentStmt.pdf.
VerDate Sep<11>2014
19:23 Mar 20, 2023
Jkt 259001
The document may be
found in the docket at
www.regulations.gov, Docket No. CDC–
2022–0044 and at https://www.cdc.gov/
mmwr/volumes/72/rr/rr7201a1.htm?s_
cid=rr7201a1_w.
FOR FURTHER INFORMATION CONTACT: Erin
Conners, Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
Mailstop U12–3, Atlanta, GA 30329.
Telephone: 404–639–8000; Email:
DVHpolicy@cdc.gov.
SUPPLEMENTARY INFORMATION: In 2022,
CDC determined that CDC
Recommendations for Hepatitis B
Screening and Testing—United States,
2022 constituted influential scientific
information (ISI) that will have a clear
and substantial impact on important
public policies and private sector
decisions. Under the Information
Quality Act, Public Law 106–554,
federal agencies are required to conduct
peer review of the information by
specialists in the field who were not
involved in the development of these
recommendations. CDC solicited
nominations for reviewers from the
American Association for the Study of
Liver Diseases (AASLD), Infectious
Diseases Society of America (IDSA) and
American College of Physicians (ACP).
Five clinicians with expertise in
hepatology, gastroenterology, internal
medicine, infectious diseases, and/or
pediatrics provided structured peer
reviews. A list of peer reviewers and
CDC’s responses to peer review
comments are available at CDC’s Viral
Hepatitis Influential Scientific
Information web page at https://
www.cdc.gov/hepatitis/policy/isireview/
index.htm.
In addition, on April 4, 2022, CDC
published a notice in the Federal
Register (87 FR 19516–19517) to obtain
public comment on the draft
recommendations for hepatitis B
screening and testing. The comment
period closed on June 3, 2022. CDC
received comments from 28 commenters
on the draft recommendations
document. Public commenters included
those from academia, the health care
sector, advocacy groups, professional
organizations, industry, the public, and
a consulting group.
Many of the comments expressed
support for the recommendations. Other
comments related to the 3-panel test
recommendation, inclusion of hepatitis
D information, the hepatitis B
prevalence estimate, modifying testing
and vaccination language, adding
scientific references, and making other
minor language modifications. CDC
addressed these comments by
correcting, clarifying, or updating
ADDRESSES:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
16981
content in the final recommendations. A
summary of public comments and
CDC’s response can be found in the
Documents tab of the docket.
Tiffany Brown,
Acting Executive Secretary, Centers for
Disease Control and Prevention.
[FR Doc. 2023–05715 Filed 3–20–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3434–FN]
Medicare and Medicaid Programs:
Application From the Accreditation
Commission for Health Care, Inc. for
Continued Approval of Its End-Stage
Renal Disease (ESRD) Accreditation
Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This final notice announces
our decision to approve the
Accreditation Commission for Health
Care, Inc for continued recognition as a
national accrediting organization for
end stage renal disease facilities that
wish to participate in the Medicare or
Medicaid programs.
DATES: The decision announced in this
final notice is applicable on April 11,
2023 through April 10, 2029.
FOR FURTHER INFORMATION CONTACT:
Joy Webb, (410) 786–1667.
Caecilia Blondiaux, (410) 786–2190.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Under the Medicare program, eligible
beneficiaries may receive covered
services from an end stage renal disease
(ESRD) facility provided certain
requirements are met. Section 1881(b) of
the Social Security Act (the Act),
establishes distinct criteria for facilities
seeking designation as an ESRD facility.
Regulations concerning provider
agreements are at 42 CFR part 489 and
those pertaining to activities relating to
the survey and certification of facilities
are at 42 CFR part 488. The regulations
at 42 CFR part 494 specify the minimum
conditions that an ESRD facility must
meet to participate in the Medicare
program.
Generally, to enter into an agreement,
an ESRD facility must first be certified
by a state survey agency (SA) as
complying with the conditions or
requirements set forth in part 494 of our
E:\FR\FM\21MRN1.SGM
21MRN1
16982
Federal Register / Vol. 88, No. 54 / Tuesday, March 21, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
regulations. Thereafter, the ESRD
facility is subject to regular surveys by
a SA to determine whether it continues
to meet these requirements.
Section 1865(a)(1) of the Act provides
that, if a provider entity demonstrates
through accreditation by a Centers for
Medicare & Medicaid Services (CMS)approved national accrediting
organization (AO) that all applicable
Medicare requirements are met or
exceeded, we will deem those provider
entities as having met such
requirements. Accreditation by an AO is
voluntary and is not required for
Medicare participation.
If an AO is recognized by the
Secretary of the Department of Health
and Human Services (the Secretary) as
having standards for accreditation that
meet or exceed Medicare requirements,
any provider entity accredited by the
national accrediting body’s approved
program would be deemed to meet the
Medicare conditions. A national AO
applying for approval of its
accreditation program under part 488,
subpart A, must provide CMS with
reasonable assurance that the AO
requires the accredited provider entities
to meet requirements that are at least as
stringent as the Medicare conditions.
Our regulations concerning the approval
of AOs are set forth at §§ 488.4, 488.5
and 488.5(e)(2)(i). The regulations at
§ 488.5(e)(2)(i) require AOs to reapply
for continued approval of its
accreditation program every 6 years or
sooner, as determined by CMS.
ACHC’s current term of approval for
their ESRD facility accreditation
program expires April 11, 2023.
II. Application Approval Process
Section 1865(a)(3)(A) of the Act
provides a statutory timetable to ensure
that our review of applications for CMSapproval of an accreditation program is
conducted in a timely manner. The Act
provides us 210 days after the date of
receipt of a complete application, with
any documentation necessary to make
the determination, to complete our
survey activities and application
process. Within 60 days after receiving
a complete application, we must
publish a notice in the Federal Register
that identifies the national accrediting
body making the request, describes the
request, and provides no less than a 30day public comment period. At the end
of the 210-day period, we must publish
a notice in the Federal Register
approving or denying the application.
III. Provisions of the Proposed Notice
On October 4, 2022, we published a
proposed notice in the Federal Register
(87 FR 60171), announcing ACHC’s
VerDate Sep<11>2014
19:23 Mar 20, 2023
Jkt 259001
request for continued approval of its
Medicare ESRD facility accreditation
program. In the October 4, 2022
proposed notice, we detailed our
evaluation criteria. Under section
1865(a)(2) of the Act and in our
regulations at § 488.5, we conducted a
review of ACHC’s Medicare ESRD
facility accreditation application in
accordance with the criteria specified by
our regulations, which include, but are
not limited to the following:
• A virtual onsite administrative
review of ACHC’s: (1) corporate
policies; (2) financial and human
resources available to accomplish the
proposed surveys; (3) procedures for
training, monitoring, and evaluation of
its ESRD surveyors; (4) ability to
investigate and respond appropriately to
complaints against accredited ESRD
facilities; and (5) survey review and
decision-making process for
accreditation.
• The comparison of ACHC’s
Medicare ESRD facility accreditation
program standards to our current
Medicare ESRD facility conditions of
participation (CoPs).
• A documentation review of ACHC’s
survey process to do the following:
++ Determine the composition of the
survey team, surveyor qualifications,
and ACHC’s ability to provide
continuing surveyor training.
++ Compare ACHC’s processes to
those we require of state survey
agencies, including periodic resurvey
and the ability to investigate and
respond appropriately to complaints
against ACHC accredited ESRD
facilities.
++ Evaluate ACHC’s procedures for
monitoring accredited ESRD facilities it
has found to be out of compliance with
ACHC’s program requirements. (This
pertains only to monitoring procedures
when ACHC identifies non-compliance.
If noncompliance is identified by a SA
through a validation survey, the SA
monitors corrections as specified at
§ 488.9(c)).
++ Assess ACHC’s ability to report
deficiencies to the surveyed ESRD
facilities and respond to the ESRD
facilities’ plans of correction in a timely
manner.
++ Establish ACHC’s ability to provide
CMS with electronic data and reports
necessary for effective validation and
assessment of the organization’s survey
process.
++ Determine the adequacy of ACHC’s
staff and other resources.
++ Confirm ACHC’s ability to provide
adequate funding for performing
required surveys.
++ Confirm ACHC’s policies with
respect to surveys being unannounced.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
++ Confirm ACHC’s policies and
procedures to avoid conflicts of interest,
including the appearance of conflicts of
interest, involving individuals who
conduct surveys or participate in
accreditation decisions.
++ Obtain ACHC’s agreement to
provide CMS with a copy of the most
current accreditation survey together
with any other information related to
the survey as we may require, including
corrective action plans.
IV. Analysis of and Responses to Public
Comments on the Proposed Notice
In accordance with section
1865(a)(3)(A) of the Act, the October 4,
2022 proposed notice also solicited
public comments regarding whether
ACHC’s requirements met or exceeded
the Medicare CoPs for ESRD facilities.
No comments were received in response
to our proposed notice.
V. Provisions of the Final Notice
A. Differences Between ACHC’s
Standards and Requirements for
Accreditation and Medicare Conditions
and Survey Requirements
We compared ACHC’s ESRD facility
accreditation requirements and survey
process with the Medicare CoPs of parts
494, and the survey and certification
process requirements of parts 488 and
489. Our review and evaluation of
ACHC’s ESRD facility accreditation
application, which were conducted as
described in section III. of this final
notice, yielded the following areas
where, as of the date of this final notice,
ACHC has completed revising its
standards and certification processes in
order to—
• Meet the standard’s requirements of
all of the following regulations:
++ Section 494.30(b)(3)(x), to clarify
and address the contingency plans for
staff who are not fully vaccinated for
COVID–19.
++ Section 494.60(d)(1), to address
dialysis facilities that do not provide
one or more exits to the outside must
comply with Life Safety Code (NFPA
101).
++ Section 494.60(d)(4), to clarify
specific Life Safety Code provisions that
may be waived, only if the waiver will
not adversely affect the health and
safety of the patients.
++ Section 494.60(d)(5), to clarify that
no dialysis facility may operate in a
building adjacent to an industrial high
hazard area.
In addition to the standards review,
CMS also reviewed ACHC’s comparable
survey processes, which were
conducted as described in section III. of
this final notice, and yielded the
E:\FR\FM\21MRN1.SGM
21MRN1
Federal Register / Vol. 88, No. 54 / Tuesday, March 21, 2023 / Notices
following areas where, as of the date of
this final notice, ACHC has completed
revising its survey processes in order to
demonstrate that it uses survey
processes that are comparable to state
survey agency processes by:
++ Revising the compliant policies
and processes to align with the State
Operations Manual, Chapter 5 guidance.
In particular, the Administrative Review
Offsite Investigation process to align
with the triage process to track and
trend for potential focus areas during
the next onsite survey or complete an
onsite complaint investigation.
++ Clarifying the quantifying data
surrounding equipment and
maintenance logs, specifically the
equipment review. The survey reports
or notes need to identify the number of
logs reviewed, date or timeframes.
++ Providing surveyor training on
documentation reviews and the process
for verifying the completeness of the
facility request.
++ Reinforcing and providing
education to facility surveyors to
request Dialysis Facility Reports, the
reports provide aggregate data regarding
laboratory values, demographic
information, mortality rates,
hospitalizations, infections, etc., which
may assist the surveyors during the
review of patient medical records.
++ Developing additional surveyor
training for verifying all elements
required for the CMS emergency
preparedness requirements.
ddrumheller on DSK120RN23PROD with NOTICES1
Based on our review and observations
described in section III. and section V.
of this final notice, we approve ACHC
as a national accreditation organization
for ESRD facilities that request
participation in the Medicare program.
The decision announced in this final
notice is effective April 11, 2023
through April 11, 2029 (6 years). In
accordance with § 488.5(e)(2)(i) the term
of the approval will not exceed 6 years.
While ACHC has taken actions based
on the findings annotated in section
V.A., of this final notice, (Differences
Between ACHC’s Standards and
Requirements for Accreditation and
Medicare Conditions and Survey
Requirements) as authorized under
§ 488.8, we will continue ongoing
review of ACHC’s ESRD survey
substance and processes. In keeping
with CMS’s initiative to increase AO
oversight broadly, and ensure that our
requested revisions by ACHC are
completed, CMS expects more frequent
review of ACHC’s activities in the
future.
19:23 Mar 20, 2023
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.)
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Chiquita Brooks-LaSure, having
reviewed and approved this document,
authorizes Evell J.Barco Holland, who is
the Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
Dated: March 15, 2023.
Evell J. Barco Holland,
Federal Register Liaison, Center for Medicare
& Medicaid Services.
[FR Doc. 2023–05761 Filed 3–20–23; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10847]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Jkt 259001
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
May 22, 2023.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
Contents
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10847 Information Collection
Request for Negotiation Data Elements
under Sections 11001 and 11002 of
the Inflation Reduction Act
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
AGENCY:
B. Term of Approval
VerDate Sep<11>2014
VI. Collection of Information
Requirements
16983
SUMMARY:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\21MRN1.SGM
21MRN1
Agencies
[Federal Register Volume 88, Number 54 (Tuesday, March 21, 2023)]
[Notices]
[Pages 16981-16983]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05761]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3434-FN]
Medicare and Medicaid Programs: Application From the
Accreditation Commission for Health Care, Inc. for Continued Approval
of Its End-Stage Renal Disease (ESRD) Accreditation Program
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This final notice announces our decision to approve the
Accreditation Commission for Health Care, Inc for continued recognition
as a national accrediting organization for end stage renal disease
facilities that wish to participate in the Medicare or Medicaid
programs.
DATES: The decision announced in this final notice is applicable on
April 11, 2023 through April 10, 2029.
FOR FURTHER INFORMATION CONTACT:
Joy Webb, (410) 786-1667.
Caecilia Blondiaux, (410) 786-2190.
SUPPLEMENTARY INFORMATION:
I. Background
Under the Medicare program, eligible beneficiaries may receive
covered services from an end stage renal disease (ESRD) facility
provided certain requirements are met. Section 1881(b) of the Social
Security Act (the Act), establishes distinct criteria for facilities
seeking designation as an ESRD facility. Regulations concerning
provider agreements are at 42 CFR part 489 and those pertaining to
activities relating to the survey and certification of facilities are
at 42 CFR part 488. The regulations at 42 CFR part 494 specify the
minimum conditions that an ESRD facility must meet to participate in
the Medicare program.
Generally, to enter into an agreement, an ESRD facility must first
be certified by a state survey agency (SA) as complying with the
conditions or requirements set forth in part 494 of our
[[Page 16982]]
regulations. Thereafter, the ESRD facility is subject to regular
surveys by a SA to determine whether it continues to meet these
requirements.
Section 1865(a)(1) of the Act provides that, if a provider entity
demonstrates through accreditation by a Centers for Medicare & Medicaid
Services (CMS)-approved national accrediting organization (AO) that all
applicable Medicare requirements are met or exceeded, we will deem
those provider entities as having met such requirements. Accreditation
by an AO is voluntary and is not required for Medicare participation.
If an AO is recognized by the Secretary of the Department of Health
and Human Services (the Secretary) as having standards for
accreditation that meet or exceed Medicare requirements, any provider
entity accredited by the national accrediting body's approved program
would be deemed to meet the Medicare conditions. A national AO applying
for approval of its accreditation program under part 488, subpart A,
must provide CMS with reasonable assurance that the AO requires the
accredited provider entities to meet requirements that are at least as
stringent as the Medicare conditions. Our regulations concerning the
approval of AOs are set forth at Sec. Sec. 488.4, 488.5 and
488.5(e)(2)(i). The regulations at Sec. 488.5(e)(2)(i) require AOs to
reapply for continued approval of its accreditation program every 6
years or sooner, as determined by CMS.
ACHC's current term of approval for their ESRD facility
accreditation program expires April 11, 2023.
II. Application Approval Process
Section 1865(a)(3)(A) of the Act provides a statutory timetable to
ensure that our review of applications for CMS-approval of an
accreditation program is conducted in a timely manner. The Act provides
us 210 days after the date of receipt of a complete application, with
any documentation necessary to make the determination, to complete our
survey activities and application process. Within 60 days after
receiving a complete application, we must publish a notice in the
Federal Register that identifies the national accrediting body making
the request, describes the request, and provides no less than a 30-day
public comment period. At the end of the 210-day period, we must
publish a notice in the Federal Register approving or denying the
application.
III. Provisions of the Proposed Notice
On October 4, 2022, we published a proposed notice in the Federal
Register (87 FR 60171), announcing ACHC's request for continued
approval of its Medicare ESRD facility accreditation program. In the
October 4, 2022 proposed notice, we detailed our evaluation criteria.
Under section 1865(a)(2) of the Act and in our regulations at Sec.
488.5, we conducted a review of ACHC's Medicare ESRD facility
accreditation application in accordance with the criteria specified by
our regulations, which include, but are not limited to the following:
A virtual onsite administrative review of ACHC's: (1)
corporate policies; (2) financial and human resources available to
accomplish the proposed surveys; (3) procedures for training,
monitoring, and evaluation of its ESRD surveyors; (4) ability to
investigate and respond appropriately to complaints against accredited
ESRD facilities; and (5) survey review and decision-making process for
accreditation.
The comparison of ACHC's Medicare ESRD facility
accreditation program standards to our current Medicare ESRD facility
conditions of participation (CoPs).
A documentation review of ACHC's survey process to do the
following:
++ Determine the composition of the survey team, surveyor
qualifications, and ACHC's ability to provide continuing surveyor
training.
++ Compare ACHC's processes to those we require of state survey
agencies, including periodic resurvey and the ability to investigate
and respond appropriately to complaints against ACHC accredited ESRD
facilities.
++ Evaluate ACHC's procedures for monitoring accredited ESRD
facilities it has found to be out of compliance with ACHC's program
requirements. (This pertains only to monitoring procedures when ACHC
identifies non-compliance. If noncompliance is identified by a SA
through a validation survey, the SA monitors corrections as specified
at Sec. 488.9(c)).
++ Assess ACHC's ability to report deficiencies to the surveyed
ESRD facilities and respond to the ESRD facilities' plans of correction
in a timely manner.
++ Establish ACHC's ability to provide CMS with electronic data and
reports necessary for effective validation and assessment of the
organization's survey process.
++ Determine the adequacy of ACHC's staff and other resources.
++ Confirm ACHC's ability to provide adequate funding for
performing required surveys.
++ Confirm ACHC's policies with respect to surveys being
unannounced.
++ Confirm ACHC's policies and procedures to avoid conflicts of
interest, including the appearance of conflicts of interest, involving
individuals who conduct surveys or participate in accreditation
decisions.
++ Obtain ACHC's agreement to provide CMS with a copy of the most
current accreditation survey together with any other information
related to the survey as we may require, including corrective action
plans.
IV. Analysis of and Responses to Public Comments on the Proposed Notice
In accordance with section 1865(a)(3)(A) of the Act, the October 4,
2022 proposed notice also solicited public comments regarding whether
ACHC's requirements met or exceeded the Medicare CoPs for ESRD
facilities. No comments were received in response to our proposed
notice.
V. Provisions of the Final Notice
A. Differences Between ACHC's Standards and Requirements for
Accreditation and Medicare Conditions and Survey Requirements
We compared ACHC's ESRD facility accreditation requirements and
survey process with the Medicare CoPs of parts 494, and the survey and
certification process requirements of parts 488 and 489. Our review and
evaluation of ACHC's ESRD facility accreditation application, which
were conducted as described in section III. of this final notice,
yielded the following areas where, as of the date of this final notice,
ACHC has completed revising its standards and certification processes
in order to--
Meet the standard's requirements of all of the following
regulations:
++ Section 494.30(b)(3)(x), to clarify and address the contingency
plans for staff who are not fully vaccinated for COVID-19.
++ Section 494.60(d)(1), to address dialysis facilities that do not
provide one or more exits to the outside must comply with Life Safety
Code (NFPA 101).
++ Section 494.60(d)(4), to clarify specific Life Safety Code
provisions that may be waived, only if the waiver will not adversely
affect the health and safety of the patients.
++ Section 494.60(d)(5), to clarify that no dialysis facility may
operate in a building adjacent to an industrial high hazard area.
In addition to the standards review, CMS also reviewed ACHC's
comparable survey processes, which were conducted as described in
section III. of this final notice, and yielded the
[[Page 16983]]
following areas where, as of the date of this final notice, ACHC has
completed revising its survey processes in order to demonstrate that it
uses survey processes that are comparable to state survey agency
processes by:
++ Revising the compliant policies and processes to align with the
State Operations Manual, Chapter 5 guidance. In particular, the
Administrative Review Offsite Investigation process to align with the
triage process to track and trend for potential focus areas during the
next onsite survey or complete an onsite complaint investigation.
++ Clarifying the quantifying data surrounding equipment and
maintenance logs, specifically the equipment review. The survey reports
or notes need to identify the number of logs reviewed, date or
timeframes.
++ Providing surveyor training on documentation reviews and the
process for verifying the completeness of the facility request.
++ Reinforcing and providing education to facility surveyors to
request Dialysis Facility Reports, the reports provide aggregate data
regarding laboratory values, demographic information, mortality rates,
hospitalizations, infections, etc., which may assist the surveyors
during the review of patient medical records.
++ Developing additional surveyor training for verifying all
elements required for the CMS emergency preparedness requirements.
B. Term of Approval
Based on our review and observations described in section III. and
section V. of this final notice, we approve ACHC as a national
accreditation organization for ESRD facilities that request
participation in the Medicare program. The decision announced in this
final notice is effective April 11, 2023 through April 11, 2029 (6
years). In accordance with Sec. 488.5(e)(2)(i) the term of the
approval will not exceed 6 years.
While ACHC has taken actions based on the findings annotated in
section V.A., of this final notice, (Differences Between ACHC's
Standards and Requirements for Accreditation and Medicare Conditions
and Survey Requirements) as authorized under Sec. 488.8, we will
continue ongoing review of ACHC's ESRD survey substance and processes.
In keeping with CMS's initiative to increase AO oversight broadly, and
ensure that our requested revisions by ACHC are completed, CMS expects
more frequent review of ACHC's activities in the future.
VI. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.)
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this
document, authorizes Evell J.Barco Holland, who is the Federal Register
Liaison, to electronically sign this document for purposes of
publication in the Federal Register.
Dated: March 15, 2023.
Evell J. Barco Holland,
Federal Register Liaison, Center for Medicare & Medicaid Services.
[FR Doc. 2023-05761 Filed 3-20-23; 8:45 am]
BILLING CODE 4120-01-P